Bajaj HealthCare Limited (NSE:BAJAJHCARE)
India · Delayed Price · Currency is INR 321.00
-48.35 (-13.09%)
Jul 22, 2026, 3:30 PM IST
Bajaj HealthCare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 6,278 | 6,110 | 5,426 | 4,734 | 6,458 | 6,799 |
| 6,278 | 6,110 | 5,426 | 4,734 | 6,458 | 6,799 | |
Revenue Growth (YoY) | 12.27% | 12.61% | 14.61% | -26.69% | -5.01% | 3.49% |
Cost of Revenue | 3,219 | 3,164 | 2,947 | 2,574 | 3,849 | 4,995 |
Gross Profit | 3,059 | 2,946 | 2,479 | 2,160 | 2,609 | 1,804 |
Selling, General & Admin | 658.68 | 627.53 | 579.02 | 446.19 | 432.72 | 412.63 |
Other Operating Expenses | 1,310 | 1,271 | 1,076 | 949.25 | 1,060 | 172.21 |
Operating Expenses | 2,258 | 2,174 | 1,934 | 1,672 | 1,665 | 761.21 |
Operating Income | 801.34 | 772.69 | 544.55 | 488.35 | 943.37 | 1,043 |
Interest Expense | -230.99 | -222.34 | -251.22 | -290.53 | -163.99 | -110.01 |
Interest & Investment Income | - | - | 5.1 | 3.29 | 4.28 | 1.72 |
Currency Exchange Gain (Loss) | - | - | 101.38 | 18.77 | - | -19.39 |
Other Non Operating Income (Expenses) | 70.68 | 71.34 | 30.58 | -6.94 | -10.09 | -17.81 |
EBT Excluding Unusual Items | 641.03 | 621.7 | 430.39 | 212.93 | 773.57 | 897.66 |
Gain (Loss) on Sale of Assets | - | - | 3.35 | 0.36 | 0.04 | - |
Asset Writedown | - | - | - | -443.28 | - | - |
Other Unusual Items | -332.47 | -332.47 | - | - | - | -1 |
Pretax Income | 308.56 | 289.23 | 460.08 | -166.76 | 781.82 | 896.85 |
Income Tax Expense | 78.27 | 76.13 | 30.79 | -23.49 | 146.5 | 182.99 |
Earnings From Continuing Operations | 230.3 | 213.1 | 429.29 | -143.27 | 635.33 | 713.86 |
Earnings From Discontinued Operations | -53.99 | -55.44 | -34.33 | -694.67 | -205.08 | - |
Net Income | 176.3 | 157.66 | 394.96 | -837.93 | 430.24 | 713.86 |
Net Income to Common | 176.3 | 157.66 | 394.96 | -837.93 | 430.24 | 713.86 |
Net Income Growth | -60.11% | -60.08% | - | - | -39.73% | -14.11% |
Shares Outstanding (Basic) | 32 | 32 | 30 | 28 | 28 | 28 |
Shares Outstanding (Diluted) | 32 | 32 | 30 | 28 | 28 | 28 |
Shares Change (YoY) | 2.60% | 5.37% | 9.09% | - | - | - |
EPS (Basic) | 5.48 | 4.98 | 13.29 | -30.36 | 15.59 | 25.87 |
EPS (Diluted) | 5.48 | 4.97 | 13.12 | -30.36 | 15.59 | 25.87 |
EPS Growth | -61.12% | -62.12% | - | - | -39.73% | -14.09% |
Free Cash Flow | - | 147.32 | 100.82 | 620.08 | -1,158 | -786.19 |
Free Cash Flow Per Share | - | 4.64 | 3.35 | 22.47 | -41.95 | -28.49 |
Dividend Per Share | - | 1.500 | 1.000 | 1.000 | 1.000 | 1.500 |
Dividend Growth | - | 50.00% | - | - | -33.33% | 71.43% |
Gross Margin | 48.73% | 48.22% | 45.68% | 45.63% | 40.39% | 26.54% |
Operating Margin | 12.76% | 12.65% | 10.04% | 10.32% | 14.61% | 15.34% |
Profit Margin | 2.81% | 2.58% | 7.28% | -17.70% | 6.66% | 10.50% |
Free Cash Flow Margin | - | 2.41% | 1.86% | 13.10% | -17.93% | -11.56% |
EBITDA | 1,078 | 1,048 | 814.6 | 800.76 | 1,216 | 1,220 |
EBITDA Margin | 17.17% | 17.15% | 15.01% | 16.91% | 18.82% | 17.94% |
D&A For EBITDA | 276.84 | 275.48 | 270.05 | 312.41 | 272.35 | 176.37 |
EBIT | 801.34 | 772.69 | 544.55 | 488.35 | 943.37 | 1,043 |
EBIT Margin | 12.76% | 12.65% | 10.04% | 10.32% | 14.61% | 15.34% |
Effective Tax Rate | 25.36% | 26.32% | 6.69% | - | 18.74% | 20.40% |
Revenue as Reported | 6,349 | 6,182 | 5,620 | 4,821 | 6,474 | 6,813 |
Advertising Expenses | - | - | 8.41 | 7.66 | 6.58 | 0.94 |